Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» type 2 diabetes
type 2 diabetes
Lantus(R) Initiation After Metformin Achieved Superior Glycemic Control Versus Sitagliptin in Type 2 Diabetes
Yahoo
Sat, 06/9/12 - 12:41 pm
Lantus
type 2 diabetes
sitagliptin
Sanofi
Symlin Use Helped Patients with Type 2 or Type 1 Diabetes Achieve More Time in Normal Glucose Range
Yahoo/Business Wire
Sat, 06/9/12 - 12:38 pm
Symlin
type 2 diabetes
diabetes
type 1 diabetes
Amylin
Once-Weekly Bydureon Provided Greater Glucose Control, Weight Loss and Lower Risk of Hypoglycemia Compared to Once- or Twice-Daily Levemir® in Type 2 Diabetes
Yahoo/Business Wire
Sat, 06/9/12 - 12:35 pm
type 2 diabetes
diabetes
Bydureon
Amylin
Alkermes
Bydureon Improved A1C, Fasting Glucose, Pulse Pressure and Weight Regardless of Baseline Body Weight in Patients with Type 2 Diabetes
Yahoo/Business Wire
Sat, 06/9/12 - 12:33 pm
Bydureon
type 2 diabetes
Amylin
Alkermes
diabetes
Byetta Provided Greater Glycemic Durability and Overall Glycemic Control than Amaryl® in Patients with Type 2 Diabetes
Yahoo/Business Wire
Sat, 06/9/12 - 12:31 pm
Byetta
Amylin
diabetes
type 2 diabetes
Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
Yahoo/PR NewsWire
Sat, 06/9/12 - 12:29 pm
LX4211
Lexicon Pharmaceuticals
diabetes
type 2 diabetes
Boehringer Ingelheim, Lilly launch new oral type 2 diabetes drug Jentadueto in US
Pharmabiz
Sat, 03/10/12 - 06:44 pm
Boehringer Ingelheim
Eli Lilly
Jentadueto
diabetes
type 2 diabetes
Halozyme says insulin drug met goals in trials
Yahoo/AP
Sat, 10/22/11 - 12:08 pm
Halozyme
insulin
Eli Lilly
diabetes
type 1 diabetes
type 2 diabetes
Humalog
PH20
Boehringer Ingelheim and Lilly's New Type 2 Diabetes Treatment Tradjenta (Linagliptin) Tablets for Adults Now Available in U.S. Pharmacies
Pharma Live
Thu, 06/16/11 - 11:25 am
Eli Lilly
Boehringer Ingelheim
type 2 diabetes
Tradjenta
Lilly, Boehringer Win FDA Approval for Type 2 Diabetes Drug
Bloomberg
Mon, 05/2/11 - 07:21 pm
Eli Lilly
FDA
diabetes
type 2 diabetes
Boehringer Ingelheim
linagliptin
High-Dose Lipitor Linked To Diabetes
Yahoo/Reuters
Tue, 03/29/11 - 08:31 am
Lipitor
diabetes
type 2 diabetes
Pfizer
China's Type 2 Diabetes Market Will Grow to $2.5 Billion in 2014
PR-Canada
Sun, 12/5/10 - 12:20 pm
China
type 2 diabetes
diabetes
American Diabetes Association Announces New Research Grant Program in Bariatric Surgery
Thu, 11/4/10 - 11:33 am
diabetes
bariatric surgery
Covidien
Ethicon-Endo Surgery
funding
type 2 diabetes
Amylin's New Diabetes Drug Well Tolerated By Sufferers
CNBC
Mon, 06/28/10 - 02:59 pm
Amylin
diabetes
Bydureon
type 2 diabetes
In a New Study, Treatment With JANUMET® (sitagliptin/metformin), Merck's Diabetes Medicine, Resulted In Significantly Greater Blood Sugar Lowering Compared with Pioglitazone
Yahoo/BusinessWire
Sun, 06/27/10 - 11:07 am
Januvia
Merck
pioglitazone
diabetes
type 2 diabetes
Actos
Takeda
Preclinical Results With XOMA 052 in Type 2 Diabetes Presented at American Diabetes Association 70th Scientific Sessions
Yahoo/Globe NewsWire
Sun, 06/27/10 - 10:59 am
XOMA 052
Xoma
diabetes
type 2 diabetes
AFREZZA Suppresses Endogenous Glucose Production More Rapidly Than Currently Available Insulin Therapy
Yahoo/BusinessWire
Sun, 06/27/10 - 10:52 am
Afrezza
MannKind
diabetes
type 2 diabetes
Amylin Soars on Roche’s Diabetes Delay
Barron's
Sat, 06/19/10 - 12:55 pm
Amylin
Roche
type 2 diabetes
Bydureon
Neurocrine agrees collaboration deal
MarketWatch
Thu, 06/17/10 - 08:36 am
Neurocrine
Boehringer Ingelheim
type 2 diabetes
BYDUREON™ FDA Review Timeline Set With PDUFA Action Date Of October 22, 2010
Medical News Today
Sun, 05/9/10 - 12:49 pm
Bydureon
Amylin
Eli Lilly
Alkermes
type 2 diabetes
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
next ›
last »